Denmark-based biology company Octarine began producing psilocybin via a brewer’s yeast called Saccharomyces cerevisiae. While producing less than previous strains of bacteria and yeast this has proven to be the cheapest method. While losing about half of the production to psilocin conversion they are trying to work through those issues. They believe that the yeast processes are too similar to our stomach digestion and converting the psilocybin to psilocin. While still useful and may have a higher binding rate to Serotonin receptors, they are trying to make more psilocybin as that’s what they are testing. The reason for all of this is to make psilocybin more available to scientists and healthcare researchers. Traditionally, Psilocybin mushrooms are grown from spores, but this process is costly and labor-intensive under good practice methods. This is a step for companies to be able to collect more data and run more tests at a cheaper rate.
Related Articles
Forage to Feast: Exploring the Biology and Culinary Magic of Morel Mushrooms
It’s a mild spring day, with the warm sun casting flecks of light on the forest floor. Deciduous tree branches tangle together overhead and close in around a grassy depression, likely the remnant of a past disruption or abandoned pathway. The mushroom forager...
The Mushroom of Immortality: Learn About Medicinal Reishi Mushrooms
Reishi, along with the entire Ganoderma Genus, is prized for its health benefits, and is among the most unique-looking fungi in our collection. In this article, we’ll discuss some of the health benefits of Reishi mushrooms and Ganoderma as a whole. We’ll also discuss...
Washington’s New Psilocybin Therapy Bill & The Future of Legal Mushrooms
At the beginning of this year, Senator Jesse Salomon along with thirteen co-sponsors, filed Senate Bill 5201. This bill would allow for psilocybin-assisted therapy in Washington State. If passed, it would structure regulations for licensed therapeutic programs using...